Table 2. Incident use in personal care (nursing) home-dwelling older adults (65+).
| Medications | SGAs | FGAs | BZDs/ZOP, ZAL | BZDs/ZOP, ZAL + SGA |
|---|---|---|---|---|
| Users/1,000 Year 1998 | 3.76 | 19.61 | 26.66 | 0.70 |
| Users/1,000 Year 2009 | 21.09 | 8.62 | 22.91 | 4.45 |
| Change in rate per quarter | 1.01* | 0.98* | 1.00 NS | 1.01* |
| Age effect 65–84 vs. 85+ | 1.21* | 1.36* | 1.13* | 1.40* |
| Region effect rural vs. urban | 0.78* | 0.85* | 0.79* | 0.74* |
| Sex effect male vs. female | 1.22* | 1.38* | 1.09* | 1.48* |
Notes.
Results for change in quarterly rate, age, region and sex effects are presented as relative rates (adjusted for age, region, sex and time). Individuals residing in PCH do not have values for SES.
- SGAs
- second generation antipsychotics
- FGAs
- first generation antipsychotics
- BZDs/ZOP, ZAL
- benzodiazepines, zopiclone, zaleplon
- NS
- not significant
- SES
- socioeconomic status
*
Indicates a statistically significant effect (p < 0.05).